000024828 000__ 01458cam\a2200445\i\4500 000024828 001__ 24828 000024828 003__ SzGeWIPO 000024828 005__ 20240708162107.0 000024828 008__ 071205s2009 enk|||||r|||| 00| 0 eng d 000024828 035__ $$a(wipo)0 000024828 035__ $$a(OCoLC)1159934621 000024828 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL 000024828 041__ $$aeng 000024828 043__ $$ae------ 000024828 050_4 $$aK1401.A15$$bJ675 000024828 08204 $$a346.048$$222 000024828 084__ $$a137$$qGB 000024828 1001_ $$aHelm, K.A. 000024828 24514 $$aThe battle over global drug markets :$$benforcement of pharmaceutical patents in the United States, Europe and Japan. 000024828 264_1 $$aOxford [England] :$$bOxford University Press,$$c2009. 000024828 300__ $$a1 volume ([11] pages) ;$$c[28] cm. 000024828 336__ $$atext$$btxt$$2rdacontent 000024828 337__ $$aunmediated$$bn$$2rdamedia 000024828 338__ $$avolume$$bnc$$2rdacarrier 000024828 4901_ $$aJournal Of Intellectual Property Law & Practice,$$x1747-1532 ;$$vGB 137 Jan 2009 Vol 4 No 1, pages 39-50 000024828 650_0 $$aIntangible property. 000024828 650_0 $$aIntellectual property. 000024828 650_0 $$aPatents$$zEurope. 000024828 650_0 $$aIntellectual property$$zEurope. 000024828 650_4 $$aPharmaceutical patents 000024828 650_4 $$aEnforcement 000024828 651_0 $$aEurope$$xCommerce$$xLaw and legislation. 000024828 651_0 $$aJapan$$xCommerce$$xLaw and legislation. 000024828 651_0 $$aUnited States$$xCommerce$$xLaw and legislation. 000024828 830_0 $$aJournal Of Intellectual Property Law & Practice ;$$vGB 137 Jan 2009 Vol 4 No 1, pages 39-50. 000024828 8564_ $$uhttp://jiplp.oxfordjournals.org/cgi/reprint/4/1/39$$y[For WIPO staff only] 000024828 903__ $$aJournal of Intellectual Property Law & Practice. 000024828 904__ $$aJournal article 000024828 942__ $$cART$$jGB 137 Jan 2009 Vol 4 No 1$$2ddc 000024828 952__ $$w2009-01-21$$p2009-0060$$u38601$$bMAIN$$10$$kGB 137$$v2009-01-21$$70$$cMain Library$$yART 000024828 980__ $$aBIB 000024828 999__ $$c27134$$d27134